Abridge, an AI startup automating medical notes, has secured a $300 million Sequence E at a $5.3 billion valuation, based on the Wall Avenue Journal. The spherical, led by Andreessen Horowitz with participation from Khosla Ventures, follows the corporate’s $250 million February fundraise at a $2.75 billion valuation.
The 7-year-old Abridge is broadly thought-about to be the chief within the more and more crowded AI-powered medical scribe market, largely resulting from its early entry and integration with Epic Methods, the dominant well being report software program.
In Q1, Abridge reached $117 million in contracted annual recurring income (a metric that features all signed recurring contacts, together with from clients which have nonetheless not been onboarded), The Data reported final month.
Together with the fundraise, Abridge introduced that it’s increasing into changing medical notes from affected person appointments into AI-powered medical codes, an providing that makes the corporate immediately aggressive with startups like CodaMetrix and a characteristic from its associate Epic Methods.
Abridge, which was based by heart specialist Shiv Rao, claims that its AI scribe know-how is utilized by over 150 of the biggest well being methods within the U.S.
